Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chubb
Boehringer Ingelheim
Cantor Fitzgerald
UBS
Cerilliant
Merck
Mallinckrodt
Harvard Business School

Generated: October 19, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: remifentanil hydrochloride

« Back to Dashboard

Remifentanil

CASRN: 132875-61-7UNII:

Manufacturing Methods

<truncated in preview>

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Dow
Julphar
McKesson
Daiichi Sankyo
Mallinckrodt
QuintilesIMS
Colorcon
Healthtrust